NASDAQ:ATNF Stock Quote
180 Life Sciences Corp is a biotechnology company focused on developing innovative therapeutic solutions across a range of medical conditions, with an emphasis on chronic inflammatory diseases and pain management
The company leverages advanced scientific research to create and commercialize novel drug candidates, utilizing its expertise in cannabinoid therapy and other emerging treatment modalities. By addressing unmet medical needs, 180 Life Sciences aims to enhance patient outcomes and improve the quality of life for individuals suffering from debilitating conditions.
Frequently Asked Questions
Has 180 Life Sciences Corp. partnered with any other organizations?
Yes, 180 Life Sciences Corp. has formed strategic partnerships with academic institutions and research organizations. These partnerships aim to accelerate development programs and enhance the company's capabilities in cannabis research and product development.
How does 180 Life Sciences Corp. approach clinical trials?
180 Life Sciences Corp. adheres to stringent regulatory standards when conducting clinical trials. The company designs its trials to rigorously test the safety and efficacy of its products, ensuring that they meet the regulatory requirements set forth by authorities such as the FDA.
How does 180 Life Sciences engage with investors?
180 Life Sciences engages with investors through regular updates, presentations, and investor calls. They aim to keep the investment community informed about the progress of their clinical trials, product development, and business strategy to foster transparency and trust.
How does 180 Life Sciences ensure product safety?
180 Life Sciences adopts rigorous quality control and safety assessment procedures in its development process. The company conducts extensive preclinical and clinical studies to ensure that its products meet safety regulations and do not pose risks to patients.
What are some key products in development by 180 Life Sciences?
Some of the key products in development by 180 Life Sciences include treatments for chronic pain, inflammation, and neurodegenerative diseases. Their pipeline focuses on leveraging the therapeutic potential of cannabinoids to provide more effective treatment options.
What are the company's current clinical trials?
The current clinical trials of 180 Life Sciences include various studies evaluating the efficacy of cannabinoid-based therapies for conditions such as pain management and inflammatory diseases. These trials are critical for demonstrating the therapeutic potential of their products.
What are the future plans for 180 Life Sciences?
The future plans for 180 Life Sciences include advancing its pipeline of cannabinoid-based therapies through clinical trials, expanding its research collaborations, and potentially exploring new markets and therapeutic areas. The company aims to drive growth while maintaining a strong focus on scientific innovation.
What distinguishes 180 Life Sciences from its competitors?
180 Life Sciences distinguishes itself from competitors through its focused approach on cannabinoid therapeutics. The company's unique emphasis on scientific research and clinical validation, combined with a tailored treatment strategy, positions it as a leader in the emerging field of cannabinoid medicine.
What does 180 Life Sciences Corp. do?
180 Life Sciences Corp. is a biotechnology company focused on developing novel therapeutics for various medical conditions. It primarily concentrates on the development of advanced therapeutic solutions using cannabis-derived compounds, particularly for pain, inflammation, and specific diseases such as fibromyalgia and Crohn's disease.
What is the company's vision for the future?
180 Life Sciences Corp. envisions becoming a leading innovator in the field of biotechnology by developing effective cannabinoid-based therapies. The company aims to improve patient outcomes and expand the therapeutic applications of cannabinoids in medicine.
What is the significance of cannabinoid research for 180 Life Sciences?
Cannabinoid research is central to 180 Life Sciences Corp.'s mission, as it seeks to unlock the medical potential of these compounds. The company's research focuses on understanding how cannabinoids interact with the body's systems to provide therapeutic benefits for various ailments.
What is the ticker symbol for 180 Life Sciences Corp.?
180 Life Sciences Corp. is traded under the ticker symbol ATNF on the Nasdaq stock exchange. This symbol represents the company's shares and is how investors can track its performance in the public market.
What markets does 180 Life Sciences target?
180 Life Sciences primarily targets the medical biotechnology market, focusing on conditions that can benefit from cannabinoid-based treatments. This includes areas like chronic pain management, inflammation, and neurological disorders.
What potential benefits do 180 Life Sciences' products offer?
The products developed by 180 Life Sciences offer the potential for reduced pain and inflammation, effective management of chronic disorders, and improved quality of life for patients suffering from conditions that are currently inadequately addressed by traditional medications.
When was 180 Life Sciences Corp. founded?
180 Life Sciences Corp. was founded in 2019 and has since been on a mission to innovate and improve treatments within the medical field. The founding team aimed to harness the potential of cannabinoids and other compounds to address unmet medical needs.
Where is 180 Life Sciences Corp. located?
180 Life Sciences Corp. is headquartered in Menlo Park, California. This location benefits from proximity to major biotech hubs and provides access to a skilled workforce and cutting-edge research institutions.
Who are the key executives of 180 Life Sciences Corp.?
Key executives of 180 Life Sciences Corp. include experienced professionals from the biotech and pharmaceutical industries. The company's leadership team features biotechnology experts and executives with a strong track record in drug development and commercialization.
Who are the target customers for 180 Life Sciences' products?
The target customers for 180 Life Sciences' products include patients suffering from chronic pain, inflammation, and other medical conditions that may benefit from cannabinoid-based treatments. The company also targets healthcare providers and institutions interested in innovative therapeutic options.
What is the current price of 180 Life Sciences Corp. - Common Stock?
The current price of 180 Life Sciences Corp. - Common Stock is 0.9850
When was 180 Life Sciences Corp. - Common Stock last traded?
The last trade of 180 Life Sciences Corp. - Common Stock was at 12:10 pm EDT on April 2nd, 2025